Related Experiment Video
Updated: Aug 6, 2026
04:33
Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Sleep and Psychiatric Comorbidities: The Clinical Overlap
Davis C Thomas1, Anu Priya Guruswamy Pandian2, Simran Gupta3
1Department of Diagnostic Sciences, Center for Temporomandibular Disorders and Orofacial Pain, Rutgers School of Dental Medicine, Newark, NJ, USA.
The Medical Clinics of North America
|July 24, 2026
Summary
Sleep disturbances and psychiatric disorders are bidirectionally linked, with poor sleep increasing psychiatric risk and symptoms worsening sleep. Insomnia is the most frequent sleep disorder seen with psychiatric conditions.
Area of Science:
- Psychiatry
- Sleep Medicine
- Neuroscience
Background:
- Sleep and psychiatric disorders exhibit strong, bidirectional associations.
- Impaired sleep acts as a risk factor for psychiatric conditions, while psychiatric symptoms can exacerbate sleep disturbances.
- Common systemic comorbidities and underlying factors link sleep and psychiatric disorders.
Purpose of the Study:
- To explore the bidirectional relationship between sleep and psychiatric comorbidities.
- To examine the overlap in clinical symptomatology between sleep and psychiatric disorders.
- To highlight insomnia as a prevalent sleep disorder in psychiatric populations.
Main Methods:
- Literature review of studies investigating sleep and psychiatric disorders.
- Analysis of clinical symptomatology and comorbidity data.
- Synthesis of evidence on shared underlying factors.
Main Results:
- A bidirectional relationship between sleep disturbances and psychiatric disorders is confirmed.
- Significant overlap exists in the clinical presentation of these conditions.
- Insomnia is identified as the most common sleep disorder associated with psychiatric disorders.
Conclusions:
- The intricate link between sleep and psychiatric health necessitates integrated treatment approaches.
- Understanding the bidirectional nature is crucial for effective management of both sleep and psychiatric conditions.
- Further research into shared mechanisms can inform novel therapeutic strategies.
Related Concept Videos
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:17Sleepwalking and Sleep Talking
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
01:07Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...